TRDA offering history
Every offering-related filing in Entrada Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 457 filings back to Nov 10, 2016.
| Date | Filing | What it means | |
|---|---|---|---|
| Dec 3, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 6, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 24, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 29, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 8, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 7, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 1, 2022 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Nov 1, 2021 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Oct 28, 2021 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Oct 28, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 25, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 8, 2021 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
TRDA offering FAQ
When did TRDA last execute an offering?
Per SEC filings, Entrada Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2024-06-24. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did TRDA last announce or register an offering?
The most recent registration is a S-3 filed 2025-11-06. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.